文献速递关节外科

新型原位固定平台假体设计在踝关节翻修置换术中的短期表现如何?一项生存、临床与影像学分析

How Does a Novel In Situ Fixed-bearing Implant Design Perform in Revision Ankle Arthroplasty in the Short Term? A Survival, Clinical, and Radiologic Analysis.
PubMed 文献 · Clin Orthop Relat Res · 2023-01-06

本研究纳入54例因既往全踝关节置换失败而采用新型H2假体行翻修的踝关节,中位随访3.2年,1年和2年重复翻修累积发生率分别为5.6%和7.4%,AOFAS踝-后足评分中位数从50升至78,VAS疼痛中位数从5降至2(均p<0.01),影像学透亮线见于12%、松动见于8%。

要点

  • 1年和2年重复翻修累积发生率分别为5.6%和7.4%。
  • AOFAS踝-后足评分中位数从术前50升至末次随访78(p<0.01)。
  • VAS疼痛中位数从术前5降至末次随访2(p<0.01)。

核心结论

  • 所研究的新型原位固定平台踝关节设计取得了优于既往研究报告的总体短期结果。
  • 踝关节复合体失稳、软组织功能不全及可能的关节构型改变需要在翻修置换术中寻找最佳解决方案;该假体可能是这一复杂问题的答案,并有助于外科医生的围手术期决策。
  • 然而,相对较高比例的患者未达到临床重要差异;需要观察性研究来了解假体的长期行为,并可能识别从翻修中获益最大的踝关节。

研究设计与样本

  • 2018年2月至2020年2月在本院因任何指征共行230例全踝关节置换术(206例患者),其中96%(220/230,201例患者)使用新型半限制性非骨水泥Hintermann Series H2®假体。
  • 220例中54%(119/220)为从既有全踝关节置换转为H2,为本研究重点;但仅45%(54/119)符合分析条件,纳入分析。
  • 纳入分析患者平均年龄63±12岁,43%(23/54)为女性,中位(范围)随访时间3.2年(2.0至4.3)。
  • 重复翻修定义为更换一个或两个金属组件、踝关节融合或截肢,采用累积发生率生存估计法评估;采用Cox回归分析评估与翻修可能相关的因素。

主要发现

  • 重复翻修1年和2年累积发生率分别为5.6%(95%CI 0%至11%)和7.4%(95%CI 0%至14%)。
  • AOFAS踝-后足评分中位数(范围)从术前50(16至94)升至末次随访78(19至100),中位数差28,p<0.01;VAS疼痛中位数(范围)从术前5(0至9)降至2(0至9),中位数差3,p<0.01。
  • 影像学透亮线见于12%(49例中6例),松动见于8%(49例中4例);其中1例出现症状性松动,属于总体接受翻修的4例患者之一。
  • 按现有例数,所分析临床因素均与重复翻修风险无关;因事件数少(4例),无法评估重复翻修的危险因素。

关键数值与推荐

  • 松动影像学定义为:胫骨组件平坦基底相对于胫骨长轴位置变化大于2°,距骨组件向距骨内下沉大于5 mm,或相对于从距舟关节顶部至跟骨结节连线位置变化大于5°(负重位平片)。
  • AOFAS踝-后足评分中位数从50(16至94)升至78(19至100),中位数差28(p<0.01)。
  • VAS疼痛(过去7天正常日常活动平均疼痛)中位数从5(0至9)降至2(0至9),中位数差3(p<0.01)。

临床怎么用

  • 原文结论认为该假体可能是翻修置换术中处理踝关节复合体失稳、软组织功能不全及关节构型改变这一复杂问题的答案,并可能有助于外科医生围手术期决策(作者认为)。
  • 原文结论指出需要观察性研究来了解假体长期行为,并可能识别从翻修中获益最大的踝关节(作者建议)。

局限性

  • 仅45%(54/119)的H2转换病例符合分析条件。
  • 因事件数少(4例),无法评估重复翻修的危险因素。
  • 相对较高比例的患者未达到临床重要差异。
  • 需要观察性研究来了解假体长期行为并可能识别获益最大的踝关节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Given the growing number of primary total ankle replacements (TAR), an increase in the number of patients undergoing subsequent revisions might be expected. Achieving a stable and balanced ankle while preserving the remaining bone stock as much as possible is crucial for success in revision TAR. Most reported techniques rely on bulky implants with extended fixation features. Since 2018, we have used a novel, three-component ankle prosthesis for revision that is converted in situ to a fixed-bearing, two-component ankle prosthesis once the components have found their position according to an individual's anatomy. The results of this novel concept (fixation, revision, pain, or function) have not, to our knowledge, been reported. QUESTIONS/PURPOSES: What are the short-term results with this new revision TAR design, in terms of (1) repeat revision surgery, (2) patient-reported outcomes on the American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot score, (3) pain according to the VAS, and (4) radiographic signs of fixation? METHODS: Between February 2018 and February 2020, we performed 230 TAR surgeries (in 206 patients) for any indication in our clinic. The novel semiconstrained, uncemented Hintermann Series H2 © implant was used in 96% (220 of 230) of procedures (201 patients). Fifty-four percent (119 of 220) of these were converted from an existing TAR to H2, which was the focus of the present study. However, only 45% (54 of 119) of these conversions to H2 were eligible for analysis. These patients had a mean age of 63 ± 12 years, and 43% (23 of 54) were women. The median (range) follow-up time was 3.2 years (2.0 to 4.3). The H2 design allows in situ conversion to a fixed-bearing system, with minimal bone resection. It achieves translational and rotational stability while preserving function and supporting the periarticular soft tissues. We defined repeat revision as exchange of one or both metal components, ankle fusion, or amputation and assessed it using a cumulative incidence survivorship estimator. Factors potentially associated with revision were assessed using Cox regression analyses. Clinical and radiologic outcomes were assessed preoperatively and at the most recent follow-up interval. Clinical outcomes included pain on the VAS (average pain during normal daily activity during the past seven days) and AOFAS score. Radiologic outcomes were the tibial articular surface angle, tibiotalar surface angle, talar tilt angle in the coronal plane, and AP offset ratio in the sagittal plane, as well as radiolucent lines and radiographic signs of loosening, defined as change in position greater than 2° of the flat base of the tibia component in relation to the long axis of the tibia, subsidence of the talar component into the talus greater than 5 mm, or change in position greater than 5° relative to a line drawn from the top of the talonavicular joint to the tuberosity of the calcaneus, as seen on plain weightbearing radiographs. RESULTS: The cumulative incidence of repeat revision after 1 and 2 years was 5.6% (95% CI 0% to 11%) and 7.4% (95% CI 0% to 14%), respectively. With the numbers available, no clinical factors we analyzed were associated with the risk of repeat revision. The median values of all assessed clinical outcomes improved; however, not all patients improved by clinically important margins. The median (range) AOFAS ankle-hindfoot score increased (from 50 [16 to 94] to 78 [19 to 100], difference of medians 28; p < 0.01), and the median pain on the VAS decreased (from 5 [0 to 9] to 2 [0 to 9], difference of medians 3; p < 0.01) from before surgery to follow-up at a minimum of 2 years. Radiographically, lucency was seen in 12% (6 of 49 patients) and loosening was seen in 8% (4 of 49). One of these patients showed symptomatic loosening and was among the four patients overall who underwent revision. We could not assess risk factors for repeat revision because of the low number of events (four). CONCLUSION: The investigated new in situ fixed-bearing ankle design achieved overall better short-term results than those reported in previous research. Destabilization of the ankle joint complex, soft tissue insufficiency, and possible changes of the joint configuration need an optimal solution in revision arthroplasty. The studied implant might be the answer to this complex issue and help surgeons in the perioperative decision-making process. However, a relatively high percentage of patients did not achieve a clinically important difference. Observational studies are needed to understand long-term implant behavior and possibly to identify ankles benefiting the most from revision. LEVEL OF EVIDENCE: Level IV, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Kvarda P, Toth L, Horn-Lang T, et al. How Does a Novel In Situ Fixed-bearing Implant Design Perform in Revision Ankle Arthroplasty in the Short Term? A Survival, Clinical, and Radiologic Analysis. Clin Orthop Relat Res. 2023. PMID: 36716098. doi:10.1097/CORR.0000000000002515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。